Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
BACKGROUND: Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease, partly owing to dyslipidaemia, which can be amenable to fibrate therapy. We designed the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study to assess the effect of fenofibrate on c...
Main Authors: | Keech, A, Simes, R, Barter, P, Best, J, Scott, R, Taskinen, MR, Forder, P, Pillai, A, Davis, T, Glasziou, P, Drury, P, Kesäniemi, Y, Sullivan, D, Hunt, D, Colman, P, d'Emden, M, Whiting, M, Ehnholm, C, Laakso, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
The need for a large-scale trial of fibrate therapy in diabetes: The rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
by: Barter, P, et al.
Published: (2004) -
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
by: Scott, R, et al.
Published: (2005) -
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
by: Tonkin, A, et al.
Published: (2012) -
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.
by: Davis, T, et al.
Published: (2011) -
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.
by: Rajamani, K, et al.
Published: (2009)